On April 10, 2024, Impulse (Qingdao) Health Tech Co.,Ltd. closed the transaction. The company has issued 27,796,976 A shares at a price of CNY 13.89 per share for the gross proceeds of CNY 386,099,996.64. The company has paid issuance expenses of CNY 6,441,317.90 and net proceeds is CNY 379,658,678.74.

The transaction included participation from new investors Tibet Jinshili Electronic Technology Co., Ltd for 2,159,827 shares for CNY 29,999,997.03, Jiang Minchao for 2,882,649 shares for CNY 40,039,994.61, Lü Feibiao for 3,241,180 shares for CNY 45,019,990.20, Zhiyuan Shenzhen Luogan 4 Private Equity Securities Investment Fund managed by Shenzhen Century Zhiyuan Private Equity Securities Fund Management Co., Ltd. for 3,599,712 shares for CNY 49,999,999.68, Lu Xiaowei for 2,159,827 shares for CNY 29,999,997.03, Tibet Xingrui Enterprise Management Services Co., Ltd. for 2,159,827 shares for CNY 29,999,997.03, Yian Difeng No. 3 Private Equity Investment Fund managed by Beijing Yian Capital Management Co., Ltd. for 3,599,712 shares for CNY 49,999,999.68, Fang Liang for 2,161,987 shares for CNY 30,029,999.43, Jingxi Changsheng No. 1 Private Equity Securities Investment Fund managed by Anhui Jingxi Private Equity Fund Management Co., Ltd. for 3,599,712 shares for CNY 49,999,999.68, Jiangxi Chinese Media Blue Ocean International Investment Co., Ltd. for 2,159,827 shares for CNY 29,999,997.03 and China Asset Management Co., Ltd. for 72,716 shares for CNY 1,010,025.24.

After the completion of this issuance, the shares subscribed by the issuing subscribers shall not be transferred within six months from the date of completion of this issuance.